Barbara W. Bodem - 20 May 2025 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Director
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
20 May 2025
Transactions value $
$0
Form type
4
Filing time
22 May 2025, 16:51:20 UTC
Previous filing
19 May 2025
Next filing
23 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bodem Barbara W. Director C/O BIOMARIN PHARMACEUTICAL INC., 770 LINDARO STREET, SAN RAFAEL /s/ Tae Sang Yoo, Attorney-in-Fact 22 May 2025 0001713893

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $0 +6.65K +96.31% $0.00 13.6K 20 May 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units granted on May 20, 2025. Price not applicable.
F2 The Reporting Person's direct holdings have been adjusted by five shares to correct a previous clerical error.